Functional Genetics, Inc.

Gaithersburg, MD 20878

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $7.24MM
First Award Date 03/01/06
Most Recent Award Date 07/01/12

Key Personnel

Last Name Name Awards Contact
Duan Roxanne Duan 1
Li Wu-Bo Li 3
Diaz Leyla S Diaz 3
Kinch Michael S. Kinch 1
Mao Hanwen Mao 2

10 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/12 - 06/30/13

DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) is a global threat to public health and poses an unprecedented challenge to drug development. HIV-1 drugs that directly target virus often fail due to rapid emergence of drug resistance. Functional Genetics (FGI) used a proprietary technology, Random Homozygous Gene Pertur...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/12 - 06/30/13
PI: Wu-Bo Li

DESCRIPTION (provided by applicant): Infection with influenza virus causes a highly contagious disease of the respiratory tract. Influenza represents a unique therapeutic challenge due to both seasonal antigen shift and drift. Conventional approaches for therapeutic targeting of influenza pathogens have consistently faced obstacles arising from ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/11 - 06/30/12

DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) is a global threat to public health and poses an unprecedented challenge to drug development. HIV-1 drugs that directly target virus often fail due to rapid emergence of drug resistance. Functional Genetics (FGI) used a proprietary technology, Random Homozygous Gene Pertur...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/11 - 06/30/12
PI: Wu-Bo Li

DESCRIPTION (provided by applicant): Infection with influenza virus causes a highly contagious disease of the respiratory tract. Influenza represents a unique therapeutic challenge due to both seasonal antigen shift and drift. Conventional approaches for therapeutic targeting of influenza pathogens have consistently faced obstacles arising from ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/10 - 06/30/11
PI: Wu-Bo Li

DESCRIPTION (provided by applicant): Infection with influenza virus causes a highly contagious disease of the respiratory tract. Influenza represents a unique therapeutic challenge due to both seasonal antigen shift and drift. Conventional approaches for therapeutic targeting of influenza pathogens have consistently faced obstacles arising from ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/10 - 06/30/11

DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) is a global threat to public health and poses an unprecedented challenge to drug development. HIV-1 drugs that directly target virus often fail due to rapid emergence of drug resistance. Functional Genetics (FGI) used a proprietary technology, Random Homozygous Gene Pertur...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 06/01/08 - 11/30/09

DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) represents a global threat to public heath and an unprecedented challenge to drug development. Most HIV-1 drug development has focused on viral targets. Unfortunately, given the rapid generation of viral resistance, there have been many failures employing this strategy. I...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 06/01/07 - 05/31/08

DESCRIPTION (provided by applicant): Human Immunodeficiency Virus (HIV-1) represents a global threat to public heath and an unprecedented challenge to drug development. Most HIV-1 drug development has focused on viral targets. Unfortunately, given the rapid generation of viral resistance, there have been many failures employing this strategy. I...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 03/01/07 - 02/28/09

DESCRIPTION (provided by applicant): The traditional antiviral approach is to design drugs targeting viral proteins. It tends to have a relatively narrow spectrum of action and frequently need to be replaced with novel drugs since high mutation rate of viral genome causes drug resistance. In addition, there are limited numbers of viral proteins ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 03/01/06 - 02/28/07

DESCRIPTION (provided by applicant): The traditional antiviral approach is to design drugs targeting viral proteins. It tends to have a relatively narrow spectrum of action and frequently need to be replaced with novel drugs since high mutation rate of viral genome causes drug resistance. In addition, there are limited numbers of viral proteins ...

Load More